Financhill
Sell
32

KPTI Quote, Financials, Valuation and Earnings

Last price:
$4.85
Seasonality move :
-5.11%
Day range:
$4.75 - $5.96
52-week range:
$3.51 - $17.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.29x
P/B ratio:
--
Volume:
267.9K
Avg. volume:
112.7K
1-year change:
-70.71%
Market cap:
$41.4M
Revenue:
$145.2M
EPS (TTM):
-$15.30

Karyopharm Therapeutics SEC Filings

Company Filed Form Type Description
KPTI
Karyopharm Therapeutics
05/08/2024 10-Q 10-Q filing on 05/08/2024 View Form
KPTI
Karyopharm Therapeutics
11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
KPTI
Karyopharm Therapeutics
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
KPTI
Karyopharm Therapeutics
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
KPTI
Karyopharm Therapeutics
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
KPTI
Karyopharm Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
KPTI
Karyopharm Therapeutics
05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
KPTI
Karyopharm Therapeutics
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
KPTI
Karyopharm Therapeutics
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
KPTI
Karyopharm Therapeutics
05/04/2021 10-Q 10-Q filing on 05/04/2021 View Form
KPTI
Karyopharm Therapeutics
11/02/2020 10-Q 10-Q filing on 11/02/2020 View Form
KPTI
Karyopharm Therapeutics
08/04/2020 10-Q 10-Q filing on 08/04/2020 View Form
KPTI
Karyopharm Therapeutics
05/05/2020 10-Q 10-Q filing on 05/05/2020 View Form
KPTI
Karyopharm Therapeutics
02/26/2020 10-K 10-K filing on 02/26/2020 View Form
KPTI
Karyopharm Therapeutics
11/04/2019 10-Q 10-Q filing on 11/04/2019 View Form
KPTI
Karyopharm Therapeutics
08/07/2019 10-Q 10-Q filing on 08/07/2019 View Form
KPTI
Karyopharm Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
KPTI
Karyopharm Therapeutics
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
KPTI
Karyopharm Therapeutics
11/08/2018 10-Q 10-Q filing on 11/08/2018 View Form
KPTI
Karyopharm Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
KPTI
Karyopharm Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
KPTI
Karyopharm Therapeutics
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
KPTI
Karyopharm Therapeutics
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
KPTI
Karyopharm Therapeutics
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
KPTI
Karyopharm Therapeutics
05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
KPTI
Karyopharm Therapeutics
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
KPTI
Karyopharm Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
KPTI
Karyopharm Therapeutics
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
KPTI
Karyopharm Therapeutics
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
KPTI
Karyopharm Therapeutics
03/15/2016 10-K 10-K filing on 03/15/2016 View Form
KPTI
Karyopharm Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
KPTI
Karyopharm Therapeutics
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock